OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting CoV-2 spike RBD and ACE-2 interaction with flavonoids of Anatolian propolis by in silico and in vitro studies in terms of possible COVID-19 therapeutics
Halil İbrahim Güler, Fulya Ay Sal, Zehra Can, et al.
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 530-548
Open Access | Times Cited: 27
Halil İbrahim Güler, Fulya Ay Sal, Zehra Can, et al.
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 530-548
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Propolis: An update on its chemistry and pharmacological applications
Rajib Hossain, Cristina Quispe, Rasel Ahmed Khan, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 86
Rajib Hossain, Cristina Quispe, Rasel Ahmed Khan, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 86
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
Ridhima Kaul, Pradipta Paul, Sanjay Kumar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11069-11069
Open Access | Times Cited: 76
Ridhima Kaul, Pradipta Paul, Sanjay Kumar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11069-11069
Open Access | Times Cited: 76
Current advances on the therapeutic potential of pinocembrin: An updated review
Mahmoud H. Elbatreek, Ismail Mahdi, Wafae Ouchari, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114032-114032
Open Access | Times Cited: 47
Mahmoud H. Elbatreek, Ismail Mahdi, Wafae Ouchari, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114032-114032
Open Access | Times Cited: 47
The Effects of Propolis on Viral Respiratory Diseases
Marcin Ożarowski, Tomasz M. Karpiński
Molecules (2023) Vol. 28, Iss. 1, pp. 359-359
Open Access | Times Cited: 23
Marcin Ożarowski, Tomasz M. Karpiński
Molecules (2023) Vol. 28, Iss. 1, pp. 359-359
Open Access | Times Cited: 23
Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets
Rittibet Yapasert, Patompong Khaw-on, Ratana Banjerdpongchai
Molecules (2021) Vol. 26, Iss. 24, pp. 7459-7459
Open Access | Times Cited: 47
Rittibet Yapasert, Patompong Khaw-on, Ratana Banjerdpongchai
Molecules (2021) Vol. 26, Iss. 24, pp. 7459-7459
Open Access | Times Cited: 47
Anti-Entry Activity of Natural Flavonoids against SARS-CoV-2 by Targeting Spike RBD
Jieru Meng, Jiazheng Liu, Lu Fu, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 160-160
Open Access | Times Cited: 16
Jieru Meng, Jiazheng Liu, Lu Fu, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 160-160
Open Access | Times Cited: 16
Development of a screening platform to discover natural products active against SARS-CoV-2 infection using lung organoid models
Jooeun Lee, Se Yun Jeong, Zijun Li, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 11
Jooeun Lee, Se Yun Jeong, Zijun Li, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 11
Therapeutic Potential of Glycosyl Flavonoids as Anti-Coronaviral Agents
Patrícia I. C. Godinho, Raquel G. Soengas, Vera L. M. Silva
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 546-546
Open Access | Times Cited: 27
Patrícia I. C. Godinho, Raquel G. Soengas, Vera L. M. Silva
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 546-546
Open Access | Times Cited: 27
Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study
Behzad Shahbazi, Ladan Mafakher, Ladan Teimoori‐Toolabi
Journal of Molecular Modeling (2022) Vol. 28, Iss. 4
Open Access | Times Cited: 14
Behzad Shahbazi, Ladan Mafakher, Ladan Teimoori‐Toolabi
Journal of Molecular Modeling (2022) Vol. 28, Iss. 4
Open Access | Times Cited: 14
Hesperetin, a Citrus Flavonoid, Ameliorates Inflammatory Cytokine-Mediated Inhibition of Oligodendroglial Cell Morphological Differentiation
Satoshi Nishino, Yoko Fujiki, Takanari Sato, et al.
Neurology International (2022) Vol. 14, Iss. 2, pp. 471-487
Open Access | Times Cited: 13
Satoshi Nishino, Yoko Fujiki, Takanari Sato, et al.
Neurology International (2022) Vol. 14, Iss. 2, pp. 471-487
Open Access | Times Cited: 13
Honey as an Adjuvant in the Treatment of COVID-19 Infection: A Review
Sónia Soares, Mélina Bornet, Clara Grosso, et al.
Applied Sciences (2022) Vol. 12, Iss. 15, pp. 7800-7800
Open Access | Times Cited: 12
Sónia Soares, Mélina Bornet, Clara Grosso, et al.
Applied Sciences (2022) Vol. 12, Iss. 15, pp. 7800-7800
Open Access | Times Cited: 12
An ensemble docking-based virtual screening and molecular dynamics simulation of phytochemical compounds from Malaysian Kelulut Honey (KH) against SARS-CoV-2 target enzyme, human angiotensin-converting enzyme 2 (ACE-2)
Che Muhammad Khairul Hisyam Ismail, Azzmer Azzar Abdul Hamid, Nur Nadiah Abdul Rashid, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-30
Open Access | Times Cited: 1
Che Muhammad Khairul Hisyam Ismail, Azzmer Azzar Abdul Hamid, Nur Nadiah Abdul Rashid, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-30
Open Access | Times Cited: 1
Consumption of Phenolic-Rich Food and Dietary Supplements as a Key Tool in SARS-CoV-19 Infection
José David Flores‐Félix, Ana C. Gonçalves, Gilberto Alves, et al.
Foods (2021) Vol. 10, Iss. 9, pp. 2084-2084
Open Access | Times Cited: 13
José David Flores‐Félix, Ana C. Gonçalves, Gilberto Alves, et al.
Foods (2021) Vol. 10, Iss. 9, pp. 2084-2084
Open Access | Times Cited: 13
Identification of phytochemicals in Qingfei Paidu decoction for the treatment of coronavirus disease 2019 by targeting the virus-host interactome
Yuyun Li, Yan Wu, Siyan Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113946-113946
Open Access | Times Cited: 8
Yuyun Li, Yan Wu, Siyan Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113946-113946
Open Access | Times Cited: 8
Can propolis and their compounds be efficacy in the treatment of coronavirus disease 2019 (COVID-19)? A systematic review
Rilcy Carla Silva Sobrinho, Ivani Rosa de Meneses, Bruna Cristina Alves, et al.
Research Society and Development (2022) Vol. 11, Iss. 8, pp. e3411830302-e3411830302
Open Access | Times Cited: 5
Rilcy Carla Silva Sobrinho, Ivani Rosa de Meneses, Bruna Cristina Alves, et al.
Research Society and Development (2022) Vol. 11, Iss. 8, pp. e3411830302-e3411830302
Open Access | Times Cited: 5
Structure-based Virtual Screening from Natural Products as Inhibitors of SARS-CoV-2 Spike Protein and ACE2 Receptor Binding and their Biological Evaluation In vitro
Timoteo Delgado-Maldonado, Luis D. González-Morales, Alfredo Juárez-Saldívar, et al.
Medicinal Chemistry (2024) Vol. 20, Iss. 5, pp. 546-553
Closed Access
Timoteo Delgado-Maldonado, Luis D. González-Morales, Alfredo Juárez-Saldívar, et al.
Medicinal Chemistry (2024) Vol. 20, Iss. 5, pp. 546-553
Closed Access
Exploring the Therapeutic Potential of Algerian Propolis: GC/MS Profiling, Protective Inclusion Complex, and In Silico Evaluation Against SARS‐CoV‐2 Main Proteases
Zahra Toutou, Sofiane Fatmi, Nacéra Chibani, et al.
Peptide Science (2024)
Closed Access
Zahra Toutou, Sofiane Fatmi, Nacéra Chibani, et al.
Peptide Science (2024)
Closed Access
Pulmonary Effects of Propolis
Aslı Elif Tanuğur Samanci, Nuray Bayar Muluk, Taylan Samancı, et al.
(2024), pp. 135-147
Closed Access
Aslı Elif Tanuğur Samanci, Nuray Bayar Muluk, Taylan Samancı, et al.
(2024), pp. 135-147
Closed Access
Anatolian Propolis: What Are the Different Features?
Aslı Elif Tanuğur Samanci, Nuray Bayar Muluk, Taylan Samancı, et al.
(2024), pp. 207-215
Closed Access
Aslı Elif Tanuğur Samanci, Nuray Bayar Muluk, Taylan Samancı, et al.
(2024), pp. 207-215
Closed Access
A Spike-Accum® Bioconjugate Protein Vaccine Confers Potent SARS-COV-2-Specific Immunity
Jean Pierre Bikorimana, Nathanael A. Caveney, Nehmé El-Hachem, et al.
(2024)
Closed Access
Jean Pierre Bikorimana, Nathanael A. Caveney, Nehmé El-Hachem, et al.
(2024)
Closed Access
LC-Q-TOF-MS phenolic profiling, data mining for antiviral compounds, and in silico analysis against SARS-CoV-2 in heritage-pigmented rice metabolome
Shrijana Rasaily, Ashrita C. Haldipur, N. Srividya
Food Bioscience (2024), pp. 105613-105613
Closed Access
Shrijana Rasaily, Ashrita C. Haldipur, N. Srividya
Food Bioscience (2024), pp. 105613-105613
Closed Access
Bee Pollen as a Source of Biopharmaceuticals for Neurodegeneration and Cancer Research: A Scoping Review and Translational Prospects
Rachid Kacemi, María G. Campos
Molecules (2024) Vol. 29, Iss. 24, pp. 5893-5893
Open Access
Rachid Kacemi, María G. Campos
Molecules (2024) Vol. 29, Iss. 24, pp. 5893-5893
Open Access
Expression of Human β-defensin 2 (hBD-2) in Pichia Pastoris and Investigation of Its Binding Efficiency with ACE-2
Şeymanur Çobanoğlu, Elif Arslan, Ayşenur YAZICI, et al.
The Protein Journal (2023) Vol. 42, Iss. 4, pp. 399-407
Open Access | Times Cited: 1
Şeymanur Çobanoğlu, Elif Arslan, Ayşenur YAZICI, et al.
The Protein Journal (2023) Vol. 42, Iss. 4, pp. 399-407
Open Access | Times Cited: 1
Flavonoids and other polyphenols against SARS-CoV-2
Shafeeq Ur Rehman, Furqan Shafqat, Bisal Fatima, et al.
Elsevier eBooks (2022), pp. 83-123
Closed Access | Times Cited: 2
Shafeeq Ur Rehman, Furqan Shafqat, Bisal Fatima, et al.
Elsevier eBooks (2022), pp. 83-123
Closed Access | Times Cited: 2
Evaluation of the Effect of Anatolian Propolis on Covid-19 in Healthcare Professionals
Özlem Arman Bilir, enes guler, Abdullah Osman Koçak, et al.
(2021)
Closed Access | Times Cited: 2
Özlem Arman Bilir, enes guler, Abdullah Osman Koçak, et al.
(2021)
Closed Access | Times Cited: 2
